Cash flow DexCom, Inc.

Stocks

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 16:00:00 2026-10-02 EDT			5-day change	1st Jan Change
85.36 ^USD	-1.01%		-1.45%	+28.61%

10-01	RBC Raises Price Target on DexCom to $105 From $90, Keeps Outperform Rating	MT
09-28	Dexcom Publishes New Report During Easd 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care	CI

e84ef269f.aKw9dEOLFnZUmgLlxAV7g7c8zxQDOPp1W6SXO0cGltY.HskLQArsYABm7EvdnWMd9dxXtX9meYwXMMzUaABjx-5Z_UgwdcpSQzncbQ

Published financial data: DEXCOM, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	2.45B	2.91B	3.62B	4.03B	4.66B
Total Revenues	2.45B	2.91B	3.62B	4.03B	4.66B
Cost of Goods Sold, Total	768M	1.03B	1.33B	1.59B	1.86B
Gross Profit	1.68B	1.88B	2.29B	2.44B	2.8B
Selling General & Admin Expenses, Total	794M	1B	1.19B	1.29B	1.29B
R&D Expenses	604M	484M	506M	552M	599M
Amortization of Goodwill and Intangible Assets - (IS)	-	7.5M	-	-	-
Other Operating Expenses, Total	1.4B	1.49B	1.69B	1.84B	1.89B
Operating Income	282M	391M	598M	600M	912M
Interest Expense, Total	-100M	-18.6M	-20.3M	-19M	-18.3M
Interest And Investment Income	-	18M	135M	134M	113M
Net Interest Expenses	-100M	-600K	115M	115M	94.4M
Income (Loss) On Equity Invest.	11.6M	200K	-	-	-
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	-1.7M	-	-3.9M	-6.2M	82.2M
EBT, Excl. Unusual Items	192M	391M	708M	709M	1.09B
Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	1.9M	-	-
Asset Writedown	-	-	-	-	-
Legal Settlements	-16.3M	-	-	-	-
Other Unusual Items	-1.5M	-	-	-	-
EBT, Incl. Unusual Items	174M	391M	710M	709M	1.09B
Income Tax Expense	19.2M	49.6M	169M	133M	252M
Earnings From Continuing Operations	155M	341M	542M	576M	836M
Net Income to Company	155M	341M	542M	576M	836M
Net Income - (IS)	155M	341M	542M	576M	836M
Net Income to Common Incl Extra Items	155M	341M	542M	576M	836M
Net Income to Common Excl. Extra Items	155M	341M	542M	576M	836M
Per Share Items
Net EPS - Basic	0.4	0.88	1.4	1.46	2.14
Basic EPS - Continuing Operations	0.4	0.88	1.4	1.46	2.14
Basic Weighted Average Shares Outstanding	387M	389M	386M	394M	390M
Net EPS - Diluted	0.39	0.82	1.3	1.42	2.09
Diluted EPS - Continuing Operations	0.39	0.82	1.3	1.42	2.09
Diluted Weighted Average Shares Outstanding	400M	428M	426M	413M	406M
Normalized Basic EPS	0.31	0.63	1.15	1.13	1.74
Normalized Diluted EPS	0.3	0.57	1.04	1.07	1.68
American Depositary Receipts Ratio (ADR)	0.02	0.02	0.02	0.02	0.02
Supplemental Items
EBITDA	366M	531M	784M	818M	1.16B
EBITA	282M	399M	636M	636M	945M
EBIT	282M	391M	598M	600M	912M
EBITDAR	398M	565M	817M	853M	1.2B
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	11.04	12.69	23.78	18.73	23.16
Current Domestic Taxes	14M	58.7M	167M	174M	44.2M
Current Foreign Taxes	10.1M	12.5M	56.7M	2.7M	25.7M
Total Current Taxes	24.1M	71.2M	224M	177M	69.9M
Deferred Domestic Taxes	2.1M	-21.9M	-79.1M	-57.2M	186M
Deferred Foreign Taxes	-7M	300K	24.1M	13.4M	-3.5M
Total Deferred Taxes	-4.9M	-21.6M	-55M	-43.8M	182M
Normalized Net Income	120M	244M	443M	443M	680M
Interest on Long-Term Debt	100M	18.6M	20.3M	19M	18.3M
Supplemental Operating Expense Items
Advertising Expense	126M	133M	181M	194M	224M
Selling and Marketing Expenses	126M	133M	181M	194M	224M
Research And Development Expense From Footnotes	604M	484M	506M	552M	599M
Net Rental Expense, Total	31.6M	34.1M	33.6M	35.2M	35M
Imputed Operating Lease Interest Expense	13.63M	2.36M	2.3M	2.06M	2.57M
Imputed Operating Lease Depreciation	17.97M	31.74M	31.3M	33.14M	32.43M
Stock-Based Comp., COGS (Total)	8.5M	11.1M	14.6M	14.4M	10.9M
Stock-Based Comp., R&D Exp. (Total)	41M	42.7M	45.5M	52.2M	49.2M
Stock-Based Comp., SG&A Exp. (Total)	63.9M	72.7M	90.7M	104M	99.5M
Total Stock-Based Compensation	113M	126M	151M	170M	160M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	1.05B	642M	566M	606M	918M
Short Term Investments	1.68B	1.81B	2.16B	1.97B	1.08B
Total Cash And Short Term Investments	2.73B	2.46B	2.72B	2.58B	2B
Accounts Receivable, Total	514M	713M	974M	1.01B	1.22B
Other Receivables	-	38.9M	13.6M	27.9M	73.8M
Total Receivables	514M	752M	988M	1.03B	1.29B
Inventory	357M	374M	591M	554M	629M
Prepaid Expenses	81.6M	48.9M	58.7M	76.3M	66.4M
Other Current Assets, Total	-	37M	64.5M	58.3M	49.2M
Total Current Assets	3.68B	3.67B	4.43B	4.3B	4.03B
Gross Property Plant And Equipment	1.12B	1.5B	1.69B	2.08B	2.5B
Accumulated Depreciation	-232M	-363M	-509M	-678M	-859M
Net Property Plant And Equipment	890M	1.14B	1.18B	1.4B	1.64B
Long-term Investments	-	19M	38.5M	119M	218M
Goodwill	26.5M	25.7M	25.2M	22.8M	24.2M
Other Intangibles, Total	22.6M	173M	134M	103M	70.8M
Deferred Tax Assets Long-Term	221M	341M	419M	481M	296M
Other Long-Term Assets, Total	19.4M	28.1M	36.5M	53.7M	60.7M
Total Assets	4.86B	5.39B	6.26B	6.48B	6.34B
Liabilities
Accounts Payable, Total	196M	238M	276M	345M	344M
Accrued Expenses, Total	430M	736M	1.22B	1.34B	1.74B
Current Portion of Long-Term Debt	-	773M	-	1.2B	-
Current Portion of Leases	23.8M	24.7M	25.8M	28.9M	28.3M
Current Income Taxes Payable	40.7M	44.8M	7.5M	3.9M	8.9M
Unearned Revenue Current, Total	2.1M	10.1M	18.4M	8M	-
Other Current Liabilities	27.9M	12.8M	12.6M	5.9M	18.1M
Total Current Liabilities	721M	1.84B	1.56B	2.93B	2.14B
Long-Term Debt	1.7B	1.2B	2.43B	1.24B	1.24B
Long-Term Leases	156M	154M	139M	124M	127M
Unearned Revenue Non Current	-	19M	7.4M	9.5M	-
Deferred Tax Liability Non Current	5.9M	4.9M	-	-	-
Other Non Current Liabilities	27.1M	44.8M	59.6M	79.9M	83.3M
Total Liabilities	2.61B	3.26B	4.2B	4.38B	3.59B
Common Stock, Total	100K	400K	400K	400K	400K
Additional Paid In Capital	2.5B	2.26B	3.51B	2.09B	2.28B
Retained Earnings	-47.4M	480M	1.02B	1.6B	2.43B
Treasury Stock	-206M	-595M	-2.45B	-1.58B	-2.08B
Comprehensive Income and Other	500K	-11.6M	-16.7M	-8M	115M
Total Common Equity	2.25B	2.13B	2.07B	2.1B	2.75B
Total Equity	2.25B	2.13B	2.07B	2.1B	2.75B
Total Liabilities And Equity	4.86B	5.39B	6.26B	6.48B	6.34B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	388M	386M	386M	391M	385M
ECS Total Common Shares Outstanding	388M	386M	385M	391M	385M
Book Value / Share	5.8	5.52	5.37	5.38	7.14
Tangible Book Value	2.2B	1.93B	1.91B	1.98B	2.65B
Tangible Book Value Per Share	5.68	5	4.95	5.06	6.89
Total Debt	1.88B	2.15B	2.6B	2.59B	1.4B
Net Debt	-849M	-307M	-125M	14.4M	-602M
Debt Equivalent Oper. Leases	253M	273M	269M	282M	280M
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	145M	159M	320M	327M	258M
Inventories - Work In Process, Total	16.2M	17.2M	30M	28.1M	105M
Inventories - Finished Goods, Total	196M	130M	210M	187M	266M
Buildings, Total	-	-	-	-	-
Machinery, Total	304M	482M	720M	949M	1.06B
Full Time Employees	6.3K	7.5K	9.5K	10.2K	11K
Part Time Employees	-	100	100	100	100
Accumulated Allowance for Doubtful Accounts (Supple)	5.4M	7.3M	9.3M	9.2M	12.5M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	155M	341M	542M	576M	836M
Depreciation & Amortization - CF	102M	148M	164M	198M	236M
Amortization of Goodwill and Intangible Assets - (CF)	-	7.5M	38.6M	36.5M	32.8M
Depreciation & Amortization, Total	102M	156M	202M	234M	268M
(Gain) Loss on Sale of Investments - (CF)	-11.6M	-200K	-1.9M	-	-
Asset Writedown & Restructuring Costs	87.1M	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-78.1M
Stock-Based Compensation (CF)	113M	126M	151M	170M	160M
Other Operating Activities, Total	129M	19.4M	-148M	-100M	151M
Change In Accounts Receivable	-75.5M	-200M	-260M	-35M	-202M
Change In Inventories	-112M	49.3M	-253M	12.4M	-63.7M
Change In Accounts Payable	58M	295M	466M	212M	347M
Change in Unearned Revenues	8.7M	11.1M	-2.6M	-8M	-11.5M
Change in Other Net Operating Assets	-11M	-129M	52M	-72.3M	33.5M
Cash from Operations	442M	670M	748M	990M	1.44B
Capital Expenditure	-389M	-365M	-237M	-359M	-364M
Cash Acquisitions	-30.2M	-3.9M	-	-	-
Investment in Marketable and Equity Securities, Total	193M	-138M	-253M	167M	899M
Other Investing Activities, Total	10.1M	-14.3M	-17.6M	-15.5M	600K
Cash from Investing	-216M	-522M	-507M	-208M	536M
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	1.23B	-	-
Total Debt Issued	-	-	1.23B	-	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-	-	-787M	-	-1.21B
Total Debt Repaid	-	-	-787M	-	-1.21B
Issuance of Common Stock	20.3M	22.5M	26.6M	28.2M	28.1M
Repurchase of Common Stock	-	-558M	-689M	-750M	-500M
Other Financing Activities, Total	-9.9M	-17.3M	-99.8M	-13M	-7M
Cash from Financing	10.4M	-552M	-319M	-735M	-1.69B
Foreign Exchange Rate Adjustments	-1.4M	-5.8M	1.5M	-7.4M	21.5M
Net Change in Cash	235M	-410M	-75.8M	39.8M	312M
Supplemental Items
Cash Interest Paid	11.6M	12.2M	12.4M	11.4M	11.4M
Cash Income Tax Paid (Refund)	16.8M	114M	212M	198M	94.4M
Levered Free Cash Flow	-197M	233M	472M	553M	720M
Unlevered Free Cash Flow	-134M	244M	485M	565M	731M
Change In Net Working Capital	137M	-82.3M	5.2M	-144M	-96.5M
Net Debt Issued / Repaid	-	-	443M	-	-1.21B

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	3.85	4.74	6.41	5.88	8.89
Return on Total Capital	4.52	5.77	8.35	8.01	12.9
Return On Equity %	7.59	16.35	25.78	27.63	34.5
Return on Common Equity	7.59	16.35	25.78	27.63	34.5
Margin Analysis
Gross Profit Margin %	68.63	64.72	63.19	60.46	60.1
SG&A Margin	32.44	34.37	32.72	31.88	27.69
EBITDA Margin %	14.95	18.24	21.64	20.28	24.96
EBITA Margin %	11.52	13.7	17.57	15.78	20.26
EBIT Margin %	11.52	13.44	16.5	14.88	19.56
Income From Continuing Operations Margin %	6.32	11.73	14.95	14.29	17.94
Net Income Margin %	6.32	11.73	14.95	14.29	17.94
Net Avail. For Common Margin %	6.32	11.73	14.95	14.29	17.94
Normalized Net Income Margin	4.89	8.39	12.22	10.99	14.59
Levered Free Cash Flow Margin	-8.04	8	13.04	13.7	15.43
Unlevered Free Cash Flow Margin	-5.48	8.4	13.39	14	15.68
Asset Turnover
Asset Turnover	0.53	0.56	0.62	0.63	0.73
Fixed Assets Turnover	3.27	2.87	3.12	3.12	3.07
Receivables Turnover (Average Receivables)	5.19	4.74	4.29	4.07	4.2
Inventory Turnover (Average Inventory)	2.59	2.76	2.76	2.79	3.18
Short Term Liquidity
Current Ratio	5.11	1.99	2.84	1.47	1.88
Quick Ratio	4.5	1.74	2.39	1.23	1.53
Operating Cash Flow to Current Liabilities	0.61	0.36	0.48	0.34	0.67
Days Sales Outstanding (Average Receivables)	70.27	76.99	85	89.83	86.98
Days Outstanding Inventory (Average Inventory)	140.68	132.23	132.16	131.37	114.96
Average Days Payable Outstanding	73.63	75.58	60.55	73.05	64.65
Cash Conversion Cycle (Average Days)	137.32	133.65	156.61	148.15	137.28
Long Term Solvency
Total Debt/Equity	83.59	100.82	125.63	123.36	50.85
Total Debt / Total Capital	45.53	50.2	55.68	55.23	33.71
LT Debt/Equity	82.54	63.42	124.38	64.71	49.82
Long-Term Debt / Total Capital	44.96	31.58	55.13	28.97	33.03
Total Liabilities / Total Assets	53.71	60.46	66.98	67.57	56.69
EBIT / Interest Expense	2.81	21.03	29.44	31.58	49.83
EBITDA / Interest Expense	3.97	30.37	40.26	44.89	65.5
(EBITDA - Capex) / Interest Expense	0.08	10.75	28.61	26.01	45.63
Total Debt / EBITDA	4.73	3.81	3.18	3.04	1.17
Net Debt / EBITDA	-2.14	-0.54	-0.15	0.02	-0.5
Total Debt / (EBITDA - Capex)	221.42	10.75	4.48	5.25	1.67
Net Debt / (EBITDA - Capex)	-99.89	-1.54	-0.22	0.03	-0.72
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	27.08	18.84	24.49	11.34	15.6
Gross Profit, 1 Yr. Growth %	31.28	12.06	21.55	6.52	14.92
EBITDA, 1 Yr. Growth %	3.36	51.72	43.25	4.34	42.3
EBITA, 1 Yr. Growth %	-5.81	47.94	57.89	0.03	48.41
EBIT, 1 Yr. Growth %	-5.81	47.18	52.79	0.38	51.97
Earnings From Cont. Operations, 1 Yr. Growth %	-68.66	57.31	58.7	6.41	45.14
Net Income, 1 Yr. Growth %	-68.66	57.31	58.7	6.41	45.14
Normalized Net Income, 1 Yr. Growth %	-16.98	52.12	81.39	-0.2	53.51
Diluted EPS Before Extra, 1 Yr. Growth %	-69.37	54.74	58.06	9.35	46.73
Accounts Receivable, 1 Yr. Growth %	20.02	38.69	36.53	3.27	20.92
Inventory, 1 Yr. Growth %	52.24	1.38	57.84	-6.31	15.94
Net Property, Plant and Equip., 1 Yr. Growth %	46.22	27.61	4.31	18.42	16.72
Total Assets, 1 Yr. Growth %	13.36	9.29	16.19	3.51	-2.23
Tangible Book Value, 1 Yr. Growth %	23.33	-2.59	-1.24	3.54	34.13
Common Equity, 1 Yr. Growth %	23.27	4.39	-2.96	1.64	30.6
Cash From Operations, 1 Yr. Growth %	-6.96	51.3	11.8	32.2	45.6
Capital Expenditures, 1 Yr. Growth %	95.58	-6.27	-35.14	51.65	1.31
Levered Free Cash Flow, 1 Yr. Growth %	-314.58	-252.31	86.43	15.86	28.69
Unlevered Free Cash Flow, 1 Yr. Growth %	-192.74	-273.24	83.04	15.28	28.02
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	28.8	22.89	21.63	17.73	13.45
Gross Profit, 2 Yr. CAGR %	34.32	21.29	16.71	13.79	10.64
EBITDA, 2 Yr. CAGR %	41.87	22.41	45.97	22.25	21.85
EBITA, 2 Yr. CAGR %	40.8	14.9	53.12	25.67	21.84
EBIT, 2 Yr. CAGR %	40.8	14.29	49.96	23.84	23.51
Earnings From Cont. Operations, 2 Yr. CAGR %	23.7	-21.22	58	29.95	24.27
Net Income, 2 Yr. CAGR %	23.7	-21.22	58	29.95	24.27
Normalized Net Income, 2 Yr. CAGR %	35.64	14.54	69.95	34.69	23.78
Diluted EPS Before Extra, 2 Yr. CAGR %	18.71	-21.41	56.39	31.47	26.67
Accounts Receivable, 2 Yr. CAGR %	34.03	29.02	37.61	18.74	11.74
Inventory, 2 Yr. CAGR %	72.7	26.32	26.5	21.6	3.16
Net Property, Plant and Equip., 2 Yr. CAGR %	50.52	36.6	15.37	11.14	17.57
Total Assets, 2 Yr. CAGR %	42.5	12.1	12.69	9.67	0.6
Tangible Book Value, 2 Yr. CAGR %	59.66	4.03	-1.91	1.12	17.85
Common Equity, 2 Yr. CAGR %	59.72	8.03	0.65	-0.69	15.22
Cash From Operations, 2 Yr. CAGR %	18.62	18.65	30.06	21.57	38.74
Capital Expenditures, 2 Yr. CAGR %	47.04	35.39	-22.03	-0.83	23.95
Levered Free Cash Flow, 2 Yr. CAGR %	182.61	31.98	87.18	47.7	22.81
Unlevered Free Cash Flow, 2 Yr. CAGR %	46.72	29.97	98.52	45.96	22.17
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	33.39	25.39	23.42	18.1	17.01
Gross Profit, 3 Yr. CAGR %	36.28	26.44	21.37	13.21	14.16
EBITDA, 3 Yr. CAGR %	32.55	42.89	30.31	30.52	28.6
EBITA, 3 Yr. CAGR %	14.83	40.98	28.2	32.86	32.84
EBIT, 3 Yr. CAGR %	14.83	40.09	25.9	31.18	32.59
Earnings From Cont. Operations, 3 Yr. CAGR %	6.77	50	-0.5	38.5	34.83
Net Income, 3 Yr. CAGR %	6.77	50	-0.5	38.5	34.83
Normalized Net Income, 3 Yr. CAGR %	3.96	55.37	33.48	42.45	40.69
Diluted EPS Before Extra, 3 Yr. CAGR %	2.46	44.16	-0.8	38.81	36.37
Accounts Receivable, 3 Yr. CAGR %	31.4	35.57	31.48	25.05	19.46
Inventory, 3 Yr. CAGR %	71.61	46.22	36.06	14.45	18.87
Net Property, Plant and Equip., 3 Yr. CAGR %	69.39	42.46	24.85	16.38	12.97
Total Assets, 3 Yr. CAGR %	36.41	31.06	13.45	9.54	5.55
Tangible Book Value, 3 Yr. CAGR %	50.62	30.78	2.25	-0.13	11.11
Common Equity, 3 Yr. CAGR %	50.29	34.17	4.24	0.98	8.81
Cash From Operations, 3 Yr. CAGR %	53.14	28.64	16.32	30.77	29.1
Capital Expenditures, 3 Yr. CAGR %	79.67	26.55	5.94	-2.67	-0.12
Levered Free Cash Flow, 3 Yr. CAGR %	19.05	111.37	52.34	60.05	41.61
Unlevered Free Cash Flow, 3 Yr. CAGR %	0.84	57.68	49.67	66.16	40.24
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	33.69	32.28	28.56	22.27	19.33
Gross Profit, 5 Yr. CAGR %	34.74	30.79	28.09	21.22	16.96
EBITDA, 5 Yr. CAGR %	49.57	82.24	37.89	35.07	26.86
EBITA, 5 Yr. CAGR %	34.58	56.48	27.85	34.93	25.62
EBIT, 5 Yr. CAGR %	34.58	55.88	26.26	33.35	24.94
Earnings From Cont. Operations, 5 Yr. CAGR %	18.72	46.71	33.63	41.63	8.75
Net Income, 5 Yr. CAGR %	18.72	46.71	33.63	41.63	8.75
Normalized Net Income, 5 Yr. CAGR %	24.19	51.73	32.94	46.74	29.58
Diluted EPS Before Extra, 5 Yr. CAGR %	14.58	41.46	29.3	38.94	9.39
Accounts Receivable, 5 Yr. CAGR %	38.29	39.65	33.85	28.57	23.2
Inventory, 5 Yr. CAGR %	51.08	52.64	52.91	35.82	21.8
Net Property, Plant and Equip., 5 Yr. CAGR %	52.08	50.8	45.27	28.99	21.89
Total Assets, 5 Yr. CAGR %	64.58	42.92	26.74	22.04	8.12
Tangible Book Value, 5 Yr. CAGR %	51.88	36.54	24.25	18	8.22
Common Equity, 5 Yr. CAGR %	51.32	38.43	25.54	18.96	8.5
Cash From Operations, 5 Yr. CAGR %	51.09	48.73	43.46	25.76	24.81
Capital Expenditures, 5 Yr. CAGR %	47.52	40.77	28.66	14.79	12.81
Levered Free Cash Flow, 5 Yr. CAGR %	48.43	66.05	32.27	86.27	40.03
Unlevered Free Cash Flow, 5 Yr. CAGR %	37.04	56.02	29.96	55.38	38.26